What did the AI & Data Insider interview cover?

The interview covered four dimensions of clinical AI: why the singular objective in healthcare changes the engineering posture, why behaviour under uncertainty is a greater risk than hallucinations, why clinician engagement should be read as rigour rather than resistance, and why provenance is a clinical safety requirement rather than a UI feature.

What is the difference between an AI hallucination and a clinical AI behaviour failure?

A hallucination is a factual error — the system generates content not present in the source data. A behaviour failure is when the system reads the data correctly but reasons about it incorrectly — surfacing a resolved item as active, missing temporal context, or treating conflicting documents as if they agreed. Behaviour failures are often more dangerous because the surface output looks correct.

What does provenance mean in a clinical AI system?

Provenance means every output is traceable to the specific source document, paragraph, and sentence that informed it. In Respocare Connect AI, the clinician can interrogate the reasoning chain behind any inference. This is treated as a clinical safety requirement, not a feature, because clinical reasoning depends on the ability to verify the working behind a conclusion.

Is Respocare Connect AI an AI scribe?

No. Respocare Connect AI is an agentic clinical AI platform that reasons across longitudinal patient records. AI scribes generate documentation from a single encounter. Respocare Connect AI operates across the full patient record, with structured retrieval, traceable reasoning, and clinician oversight built into the architecture. Documentation is one capability among several, not the core function.

What stage is Respocare Connect AI at?

The platform is currently in Phase 2 clinical trials with specialist partners, with documented behavioural validation across multiple structured evaluation series. The platform does not diagnose, prescribe, or replace clinical judgment. All outputs require clinician review and approval.

Is Respocare Connect AI compliant with South African regulation?

Respocare Connect AI operates in alignment with HPCSA professional standards and POPIA data protection requirements. The platform is built on a stable, audit-ready data layer with controlled access, traceable reasoning, and clinician-led oversight throughout.

Respocare Connect AI Featured in AI & Data Insider on Clinical AI

Matthew Hellyar
3 days ago
3 min read

THE INTERVIEW

Yolande D'Mello, a journalist with fifteen years covering enterprise technology, opened the conversation with a question that should be asked of every clinical AI developer but rarely is: what is the fundamental difference between AI in healthcare and AI in every other industry?

The answer was direct. Healthcare is different because the objective is singular. The patient. Every system, every workflow, every design decision ultimately converges on that single point — and that level of responsibility changes everything about how a system must be built, tested, and deployed.

"The tolerance for error is closer to launching a rocket than shipping software." — Matthew Hellyar, AI & Data Insider, 30 April 2026

The interview then moved to the dimension that the industry is only beginning to take seriously. The biggest risk in clinical AI is not hallucinations. It is behaviour. How a system responds under uncertainty. How it handles missing data. When it defers rather than generates.

A system that appears accurate most of the time but behaves unpredictably in edge cases introduces serious clinical risk. Most current evaluations do not measure this dimension. Most deployments do not test for it.

Respocare Connect AI encountered this directly in early clinical testing. A resolved clinical item was surfaced as an active concern. Not a hallucination. Not a factual error. A logic gap in how the system reasoned about time and clinical state. The output looked correct on the surface. The clinical implication was wrong. That observation became a non-negotiable design principle inside the platform: AI must reason about the state of the patient — not just the content of the record.

The interview also addressed the persistent narrative that clinicians resist AI. Matthew challenged it directly:

"Clinicians are not resistant. They are rigorous. Those are very different things — and the industry does them a disservice by confusing the two." — Matthew Hellyar, AI & Data Insider, 30 April 2026

The final dimension covered provenance. In Respocare Connect AI, every output is fully provenance-linked. The clinician can see exactly which source document informed each response. This is not a feature — it is a clinical safety requirement. Any system that cannot show its reasoning chain should not be deployed in a clinical environment.

WHY THIS INTERVIEW MATTERS IN CLINICAL AI

The interview was published alongside content from NVIDIA, IBM, and SandboxAQ contributors. For a South African agentic clinical AI platform currently in Phase 2 clinical trials, that placement is meaningful — but the more important signal is the substance of the conversation itself.

Most coverage of clinical AI is still organised around capability. Can it generate a SOAP note. Can it summarise a record. Can it draft a referral letter. These are useful questions. They are no longer the most important ones.

The questions Respocare Connect AI was built to answer are different. They are questions about how the system behaves under real clinical constraint — fragmented records, conflicting signals, longitudinal complexity, the moments where the model has to choose between generating an answer and acknowledging the limits of what it knows.

That is the work the platform is doing now, in active clinical trials with specialist partners.

THE LONGER COMMENTARY

A longer reflection on the four questions raised in the interview — written in the days after the conversation ran — has been published on Respocare Insights.

Read the deeper analysis: Behaviour, Not Hallucinations: What the Industry Is Still Getting Wrong About Clinical AI

The Insights piece sits with each of the four standards the interview implied — the singular objective in healthcare, behaviour as the real risk surface, the distinction between clinician resistance and clinical rigour, and provenance as a safety architecture rather than a UI feature.

READ THE FULL INTERVIEW

The complete interview, including questions and answers not covered here, is available at AI & Data Insider:

Clinical AI in Healthcare: Why Behaviour, Traceability and Clinician Oversight Matter

ABOUT RESPOCARE CONNECT AI

Respocare Connect AI is a South African agentic clinical AI platform built for specialist clinicians. The platform is currently in Phase 2 clinical trials, with documented behavioural validation across structured evaluation series. Respocare Connect AI does not diagnose, prescribe, or replace clinical judgment. All outputs require clinician review and approval. The platform operates in alignment with HPPIA professional standards and POPIA data protection requirements.

Early access for specialist clinicians: www.respocareconnectai.com